vs
Ardmore Shipping Corp（ASC）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
Ardmore Shipping Corp的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.1倍（$81.2M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs -15.5%），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs -6.0%）
阿德莫尔航运是一家全球化海上运输企业，持有并运营中型成品油轮与化学品运输船队，可为全球能源、化工及贸易领域客户提供石油产品、特种化学品及其他散装液态货物的海运服务。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
ASC vs PBYI — 直观对比
营收规模更大
ASC
是对方的1.1倍
$75.5M
营收增速更快
PBYI
高出43.2%
-15.5%
两年增速更快
PBYI
近两年复合增速
-6.0%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $81.2M | $75.5M |
| 净利润 | $12.8M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | 16.1% | 22.7% |
| 净利率 | 15.7% | — |
| 营收同比 | -15.5% | 27.7% |
| 净利润同比 | -47.0% | — |
| 每股收益（稀释后） | $0.30 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASCPBYI
| Q4 25 | — | $75.5M | ||
| Q3 25 | $81.2M | $54.5M | ||
| Q2 25 | $72.0M | $52.4M | ||
| Q1 25 | $74.0M | $46.0M | ||
| Q4 24 | — | $59.1M | ||
| Q3 24 | $96.1M | $80.5M | ||
| Q2 24 | $121.3M | $47.1M | ||
| Q1 24 | $106.3M | $43.8M |
净利润ASCPBYI
| Q4 25 | — | — | ||
| Q3 25 | $12.8M | $8.8M | ||
| Q2 25 | $9.6M | $5.9M | ||
| Q1 25 | $6.3M | $3.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | $24.1M | $20.3M | ||
| Q2 24 | $62.7M | $-4.5M | ||
| Q1 24 | $39.2M | $-4.8M |
毛利率ASCPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率ASCPBYI
| Q4 25 | — | 22.7% | ||
| Q3 25 | 16.1% | 17.6% | ||
| Q2 25 | 13.5% | 12.7% | ||
| Q1 25 | 8.6% | 8.7% | ||
| Q4 24 | — | 22.6% | ||
| Q3 24 | 25.4% | 27.4% | ||
| Q2 24 | 51.3% | -4.6% | ||
| Q1 24 | 37.2% | -5.3% |
净利率ASCPBYI
| Q4 25 | — | — | ||
| Q3 25 | 15.7% | 16.2% | ||
| Q2 25 | 13.3% | 11.2% | ||
| Q1 25 | 8.5% | 6.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | 25.1% | 25.2% | ||
| Q2 24 | 51.7% | -9.6% | ||
| Q1 24 | 36.9% | -11.0% |
每股收益（稀释后）ASCPBYI
| Q4 25 | — | $0.26 | ||
| Q3 25 | $0.30 | $0.17 | ||
| Q2 25 | $0.22 | $0.12 | ||
| Q1 25 | $0.14 | $0.06 | ||
| Q4 24 | — | $0.40 | ||
| Q3 24 | $0.55 | $0.41 | ||
| Q2 24 | $1.47 | $-0.09 | ||
| Q1 24 | $0.92 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $97.5M |
| 总债务越低越好 | $116.1M | $22.7M |
| 股东权益账面价值 | $628.2M | $130.3M |
| 总资产 | $799.8M | $216.3M |
| 负债/权益比越低杠杆越低 | 0.18× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资ASCPBYI
| Q4 25 | — | $97.5M | ||
| Q3 25 | — | $94.4M | ||
| Q2 25 | — | $96.0M | ||
| Q1 25 | — | $93.2M | ||
| Q4 24 | — | $101.0M | ||
| Q3 24 | — | $96.7M | ||
| Q2 24 | — | $96.8M | ||
| Q1 24 | — | $107.2M |
总债务ASCPBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | $116.1M | $34.0M | ||
| Q2 25 | $25.0M | $45.3M | ||
| Q1 25 | $20.5M | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | $22.5M | $79.3M | ||
| Q2 24 | $44.2M | $90.7M | ||
| Q1 24 | $23.1M | $102.0M |
股东权益ASCPBYI
| Q4 25 | — | $130.3M | ||
| Q3 25 | $628.2M | $115.3M | ||
| Q2 25 | $618.3M | $104.7M | ||
| Q1 25 | $610.7M | $97.1M | ||
| Q4 24 | — | $92.1M | ||
| Q3 24 | $627.0M | $71.1M | ||
| Q2 24 | $617.7M | $48.5M | ||
| Q1 24 | $567.9M | $51.0M |
总资产ASCPBYI
| Q4 25 | — | $216.3M | ||
| Q3 25 | $799.8M | $202.9M | ||
| Q2 25 | $703.8M | $194.9M | ||
| Q1 25 | $690.4M | $196.2M | ||
| Q4 24 | — | $213.3M | ||
| Q3 24 | $722.8M | $220.7M | ||
| Q2 24 | $742.0M | $205.0M | ||
| Q1 24 | $704.1M | $214.1M |
负债/权益比ASCPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | 0.18× | 0.30× | ||
| Q2 25 | 0.04× | 0.43× | ||
| Q1 25 | 0.03× | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | 0.04× | 1.12× | ||
| Q2 24 | 0.07× | 1.87× | ||
| Q1 24 | 0.04× | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $17.9M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | — | $14.4M |
| 自由现金流率自由现金流/营收 | — | 19.1% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | 1.40× | — |
| 过去12个月自由现金流最近4个季度 | — | $41.7M |
8季度趋势，按日历期对齐
经营现金流ASCPBYI
| Q4 25 | — | $14.4M | ||
| Q3 25 | $17.9M | $9.7M | ||
| Q2 25 | $11.2M | $14.1M | ||
| Q1 25 | $26.3M | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | $39.9M | $11.0M | ||
| Q2 24 | $48.4M | $1.0M | ||
| Q1 24 | $49.2M | $11.2M |
自由现金流ASCPBYI
| Q4 25 | — | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | — | $1.0M | ||
| Q1 24 | — | — |
自由现金流率ASCPBYI
| Q4 25 | — | 19.1% | ||
| Q3 25 | — | 17.7% | ||
| Q2 25 | — | 26.8% | ||
| Q1 25 | — | 7.7% | ||
| Q4 24 | — | 26.4% | ||
| Q3 24 | — | 13.7% | ||
| Q2 24 | — | 2.1% | ||
| Q1 24 | — | — |
资本支出强度ASCPBYI
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.0% |
现金转化率ASCPBYI
| Q4 25 | — | — | ||
| Q3 25 | 1.40× | 1.10× | ||
| Q2 25 | 1.17× | 2.41× | ||
| Q1 25 | 4.20× | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.65× | 0.54× | ||
| Q2 24 | 0.77× | — | ||
| Q1 24 | 1.25× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
